Gastroesophageal Reflux Disease and Connective Tissue Disorders: Pathophysiology and Implications for Treatment

作者: Marco G. Patti , Warren J. Gasper , Piero M. Fisichella , Ian Nipomnick , Francesco Palazzo

DOI: 10.1007/S11605-008-0674-9

关键词:

摘要: It has been postulated that in patients with connective tissue disorders (CTD) and gastroesophageal reflux disease (GERD), esophageal function is generally deteriorated, often complete absence of peristalsis. This belief led to the common recommendation avoiding antireflux surgery for fear creating or worsening dysphagia. We hypothesized most CTD GERD: (a) preserved; (b) peristalsis more frequently absent when end-stage lung (ESLD) also present; (c) a tailored surgical approach (partial total fundoplication) based on findings manometry allows control symptoms without high incidence postoperative Forty-eight were evaluated by 24-hour pH monitoring (EFT). Twenty (group A) had EFT because foregut symptoms, 28 ESLD B) as part transplant evaluation. Two hundred eighty-six consecutive GERD served group C). A laparoscopic fundoplication was performed two (total), eight B (three total, five partial) all C (total). Esophageal preserved GERD. In contrast, about half present. resulted patients. One patient only developed dysphagia, which resolved Savary dilatations. These data show motor CTD, so they should be offered early course their prevent respiratory complications. whom absent, partial rather than performed, it while

参考文章(29)
Barry J. Zamost, Joel Hirschberg, Andrew F. Ippoliti, Daniel E. Furst, Phillip J. Clements, Wilfred M. Weinstein, Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology. ,vol. 92, pp. 421- 428 ,(1987) , 10.1016/0016-5085(87)90137-5
R. A. Hinder, T. R. Demeester, M. Albertucci, H. J. Stein, W. Schwizer, L. Bonavina, J. R. Jamieson, Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. The American Journal of Gastroenterology. ,vol. 87, pp. 1102- 1111 ,(1992) , 10.1111/J.1572-0241.1992.TB07351.X
P. JANIAK, M. THUMSHIRN, D. MENNE, M. FOX, S. HALIM, M. FRIED, P. BRÜHLMANN, O. DISTLER, W. SCHWIZER, Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis – a randomized controlled, cross‐over trial Alimentary Pharmacology & Therapeutics. ,vol. 26, pp. 1259- 1265 ,(2007) , 10.1111/J.1365-2036.2007.03469.X
Andrew F. Ippoliti, Wilfred M. Weinstein, Barry J. Zamost, Daniel E. Furst, Joel Hirschberg, Phillip J. Clements, Esophagitis in scleroderma Gastroenterology. ,vol. 92, pp. 421- 428 ,(1987) , 10.5555/URI:PII:0016508587901375
P.J. Kahrilas, W.J. Dodds, W.J. Hogan, Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. ,vol. 94, pp. 73- 80 ,(1988) , 10.1016/0016-5085(88)90612-9
Marco G Patti, Piero M Fisichella, Silvana Perretta, None, Preoperative evaluation of patients with gastroesophageal reflux disease. Journal of Laparoendoscopic & Advanced Surgical Techniques. ,vol. 11, pp. 327- 331 ,(2001) , 10.1089/10926420152761833
J. P. SHOENUT, J. A. WIELER, A. B. MICFLIKIER, The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole. Alimentary Pharmacology & Therapeutics. ,vol. 7, pp. 509- 513 ,(2007) , 10.1111/J.1365-2036.1993.TB00126.X
Roberto O Dantas, Ulysses G Meneghelli, Ricardo B Oliveira, Marcia G Villanova, None, Esophageal dysfunction does not always worsen in systemic sclerosis Journal of Clinical Gastroenterology. ,vol. 17, pp. 281- 285 ,(1993) , 10.1097/00004836-199312000-00003
I. Mainie, R. Tutuian, A. Agrawal, D. Adams, D. O. Castell, Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. British Journal of Surgery. ,vol. 93, pp. 1483- 1487 ,(2006) , 10.1002/BJS.5493